Plasma Proteomics Study Between the Frequent Exacerbation and Infrequent Exacerbation Phenotypes of Chronic Obstructive Pulmonary Disease

References

• Celli BR, Wedzicha JA . Update on clinical aspects of chronic obstructive pulmonary disease. N Engl J Med. 2019;381(13):1257–1266. doi:10.1056/NEJMra1900500
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931.
   PubMed Web of Science ®Google Scholar
• Thomas M, Radwan A, Stonham C, Marshall S. COPD Exacerbation Frequency, Pharmacotherapy and Resource Use: an Observational Study in UK Primary Care. COPD. 2014;11(3):300–309.
   PubMedGoogle Scholar
• Ko FW, Chan KP, Hui DS, et al. Acute exacerbation of COPD. Respirology. 2016;21(7):1152–1165.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138.
   PubMed Web of Science ®Google Scholar
• Tashkin DP. Frequent exacerbations of chronic obstructive pulmonary disease--A distinct phenotype? N Engl J Med. 2010;363(12):1183–1184.
   PubMed Web of Science ®Google Scholar
• Fernandez-Costa C, Martinez-Bartolome S, McClatchy DB, Saviola AJ, Yu NK, Yates JR. Impact of the Identification Strategy on the Reproducibility of the DDA and DIA Results. J Proteome Res. 2020;19(8):3153–3161.
   PubMed Web of Science ®Google Scholar
• Willems P, Fels U, Staes A, Gevaert K, Van Damme P. Use of hybrid data-dependent and -independent acquisition spectral libraries empowers dual-proteome profiling. J Proteome Res. 2021;20(2):1165–1177.
   PubMed Web of Science ®Google Scholar
• Barkovits K, Pacharra S, Pfeiffer K, et al. Reproducibility, Specificity and Accuracy of Relative Quantification Using Spectral Library-based Data-independent Acquisition. Mol Cell Proteomics. 2020;19(1):181–197.
   PubMed Web of Science ®Google Scholar
• Bilbao A, Varesio E, Luban J, et al. Processing strategies and software solutions for data-independent acquisition in mass spectrometry. Proteomics. 2015;15(5–6):964–980.
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Gold executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.
   PubMed Web of Science ®Google Scholar
• Baralla A, Fois AG, Sotgiu E, et al. Plasma proteomic signatures in early chronic obstructive pulmonary disease. Proteomics Clin Appl. 2018;12(3):e1700088.
   PubMed Web of Science ®Google Scholar
• Regan EA, Hersh CP, Castaldi PJ, et al. Omics and the Search for Blood Biomarkers in Chronic Obstructive Pulmonary Disease. Insights from COPDGene. Am J Respir Cell Mol Biol. 2019;61(2):143–149.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu H, Li C, Ma C, Ge W. Proteome Profiling of Lung Tissues in Chronic Obstructive Pulmonary Disease (COPD): platelet and Macrophage Dysfunction Contribute to the Pathogenesis of COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:973–980.
   PubMed Web of Science ®Google Scholar
• Singh D, Fox SM, Tal-Singer R, Bates S, Riley JH, Celli B. Altered gene expression in blood and sputum in COPD frequent exacerbators in the ECLIPSE cohort. PLoS One. 2014;9(9):e107381.
   PubMed Web of Science ®Google Scholar
• Sun P, Ye R, Wang C, Bai S, Zhao L. Identification of proteomic signatures associated with COPD frequent exacerbators. Life Sci. 2019;230:1–9.
   PubMed Web of Science ®Google Scholar
• Hoenderdos K, Lodge KM, Hirst RA, et al. Hypoxia upregulates neutrophil degranulation and potential for tissue injury. Thorax. 2016;71(11):1030–1038.
   PubMed Web of Science ®Google Scholar
• Lodge KM, Vassallo A, Liu B, et al. Hypoxia increases the potential for neutrophil-mediated endothelial damage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2022;205(8):903–916.
   PubMed Web of Science ®Google Scholar
• Zhang K, Han K, Liu H, Zheng C. Circulating Complement C1q as a Novel Biomarker is Associated with the Occurrence and Development of COPD. Int J Chron Obstruct Pulmon Dis. 2022;17:395–404.
   PubMed Web of Science ®Google Scholar
• Husebo GR, Gabazza EC, D’Alessandro C, et al. Coagulation markers as predictors for clinical events in COPD. Respirology. 2021;26(4):342–351.
   PubMed Web of Science ®Google Scholar
• Morris SM. Arginine Metabolism Revisited. J Nutr. 2016;146(12):2579S–2586S.
   PubMed Web of Science ®Google Scholar
• Ruzsics I, Nagy L, Keki S, et al. L-Arginine Pathway in COPD Patients with Acute Exacerbation: a New Potential Biomarker. COPD. 2016;13(2):139–145.
   PubMedGoogle Scholar
• Parmaksiz ET, Inal A, Salepci B, et al. Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease. Lung India. 2018;35(3):199–203.
   PubMed Web of Science ®Google Scholar
• van den Berg MP, Meurs H, Gosens R. Targeting arginase and nitric oxide metabolism in chronic airway diseases and their co-morbidities. CurrOpinPharmacol. 2018;40:126–133.
   Google Scholar
• Sprouse C, Tosi LL, Gordish-Dressman H, et al. CK-MM polymorphism is associated with physical fitness test scores in military recruits. Mil Med. 2015;180(9):1001–1005.
   PubMed Web of Science ®Google Scholar
• Shankaran M, King CL, Angel TE, et al. Circulating protein synthesis rates reveal skeletal muscle proteome dynamics. J Clin Invest. 2016;126(1):288–302.
   PubMed Web of Science ®Google Scholar
• Kadereit B, Kumar P, Wang WJ, et al. Evolutionarily conserved gene family important for fat storage. Proc Natl Acad Sci U S A. 2008;105(1):94–99.
   PubMed Web of Science ®Google Scholar
• Goh VJ, Silver DL. The lipid droplet as a potential therapeutic target in NAFLD. Semin Liver Dis. 2013;33(4):312–320.
   PubMed Web of Science ®Google Scholar
• Bailey AP, Koster G, Guillermier C, et al. Antioxidant Role for Lipid Droplets in a Stem Cell Niche of Drosophila. Cell. 2015;163(2):340–353.
   PubMed Web of Science ®Google Scholar
• Yan C, Xia X, He J, et al. MyoD Is a Novel Activator of Porcine FIT1 Gene by Interacting with the Canonical E-Box Element during Myogenesis. Int J Mol Sci. 2015;16(10):25014–25030.
   PubMed Web of Science ®Google Scholar
• Mormeneo E, Jimenez-Mallebrera C, Palomer X, et al. PGC-1alpha induces mitochondrial and myokine transcriptional programs and lipid droplet and glycogen accumulation in cultured human skeletal muscle cells. PLoS One. 2012;7(1):e29985.
   PubMed Web of Science ®Google Scholar
• Rutten EP, Franssen FM, Engelen MP, Wouters EF, Deutz NE, Schols AM. Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2006;83(4):829–834.
   PubMed Web of Science ®Google Scholar
• Ryrso CK, Thaning P, Siebenmann C, et al. Effect of endurance versus resistance training on local muscle and systemic inflammation and oxidative stress in COPD. Scand J Med Sci Sports. 2018;28(11):2339–2348.
   PubMed Web of Science ®Google Scholar
• Tsutsumi A, Chubachi S, Irie H, et al. Characteristics of chronic obstructive pulmonary disease patients with robust progression of emphysematous change. Sci Rep. 2021;11(1):9548.
   PubMed Web of Science ®Google Scholar
• Hallin R, Koivisto-Hursti UK, Lindberg E, Janson C. Nutritional status, dietary energy intake and the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2006;100(3):561–567.
   PubMed Web of Science ®Google Scholar
• Martinez-Luna N, Orea-Tejeda A, Gonzalez-Islas D, et al. Association between body composition, sarcopenia and pulmonary function in chronic obstructive pulmonary disease. BMC Pulm Med. 2022;22(1):106.
   PubMed Web of Science ®Google Scholar
• Tomioka R, Kawayama T, Suetomo M, et al. ”Frequent exacerbator” is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:207–216.
   PubMed Web of Science ®Google Scholar
• Wu YK, Su WL, Yang MC, Chen SY, Wu CW, Lan CC. Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients. Int J Chron Obstruct Pulmon Dis. 2021;16:2475–2485.
   PubMed Web of Science ®Google Scholar
• McGarvey L, Lee AJ, Roberts J, Gruffydd-Jones K, McKnight E, Haughney J. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population. Respir Med. 2015;109(2):228–237.
   PubMed Web of Science ®Google Scholar
• Ozyilmaz E, Kokturk N, Teksut G, Tatlicioglu T. Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease. Int J Clin Pract. 2013;67(7):691–697.
   PubMed Web of Science ®Google Scholar
• Gu Z, Shen Y, Tang XY, et al. Genetic risk of FCRL3 and FCRL5 polymorphisms in children with asthma and allergic rhinitis in a Chinese Han population. Int J PediatrOtorhinolaryngol. 2019;120:58–63.
   PubMed Web of Science ®Google Scholar
• Lee JS, Kim JH, Bae JS, et al. Association analysis of UBE3C polymorphisms in Korean aspirin-intolerant asthmatic patients. Ann Allergy Asthma Immunol. 2010;105(4):307–312.
   PubMed Web of Science ®Google Scholar
• Hardavella G, Tzortzaki EG, Siozopoulou V, et al. Lymphangiogenesis in COPD: another link in the pathogenesis of the disease. Respir Med. 2012;106(5):687–693.
   PubMed Web of Science ®Google Scholar
• Rumora L, Rajkovic MG, Kopcinovic LM, Pancirov D, Cepelak I, Grubisic TZ. Paraoxonase 1 activity in patients with chronic obstructive pulmonary disease. COPD. 2014;11(5):539–545.
   PubMedGoogle Scholar
• GrdicRajkovic M, Popovic-Grle S, VukicDugac A, et al. PON1 gene polymorphisms in patients with chronic obstructive pulmonary disease. J Clin Pathol. 2018;71(11):963–970.
   PubMed Web of Science ®Google Scholar
• Sidhaye VK, Chau E, Breysse PN, King LS. Septin-2 mediates airway epithelial barrier function in physiologic and pathologic conditions. Am J Respir Cell Mol Biol. 2011;45(1):120–126.
   PubMed Web of Science ®Google Scholar
• Hirvonen K, Korhonen T, Salomaa V, Mannisto S, Kaprio J. Association of the DBH Polymorphism rs3025343 With Smoking Cessation in a Large Population-Based Sample. Nicotine Tob Res. 2017;19(9):1112–1115.
   PubMed Web of Science ®Google Scholar
• Siedlinski M, Cho MH, Bakke P, et al. Genome-wide association study of smoking behaviours in patients with COPD. Thorax. 2011;66(10):894–902.
   PubMed Web of Science ®Google Scholar